Unlock Strategic Intelligence with Fundz
Access exclusive insights on funding rounds, strategic shifts with FundzWatch™, Family Offices, and more — faster than your competitors.
Forge Biologics Closes $80 Million In Additional Financing To Accelerate Planned Cdmo Expansion
01/10/22, 1:00 PM
Location
columbusMoney raised
$80 million
Industry
health care
Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today 2022 manufacturing expansion plans to meet the growing demand for gene therapy manufacturing. The expansion will coincide with an accelerated increase in headcount and expansion of The Hearth facility in Columbus, Ohio, both aided by continued investments in the company.
🔒 Strategic shifts and deeper insights are available for this company. Unlock full access to view hidden updates, executive moves, and more.
Company Info
Location
columbus, mississippi, united states
Additional Info
Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 200,000+ square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit www.forgebiologics.com
Track Every New Funding Round — Before Anyone Else
This is just a small preview. Unlock access to thousands more filtered results — updated in real-time by stage, region, investor & more.
Trusted by sales, BD, and investment teams at Oracle, HubSpot, Affinity, and more.